Background: Zinc protoporphyrin (ZPP) testing has been studied previously as a substitute for ferritin (fer) testing of blood donors in determining iron stores.
Blood colelction agencies must maintain safe inventory to meet the demand of the healthcare institutions they serve. In doing so, they must also be attentive to the health of their volunteer donors. Iron-deficiency anemia is a factor that restricts the frequency of repeat blood donation.
Zinc protoporphyrin (ZPP) is the main form of nonheme protoporphyrin present in red blood cells (RBCs) with iron depletion. Raised levels of ZPP in RBCs indicates diminished iron stores and a decline in the available iron in bone marrow. 1 3, 4 For practical reasons, our blood center sought to determine whether ZPP levels could be assayed in a manner similar to the way we test predonation HB levels, namely, using blood specimens collected via capillary (cap) finger-stick (FS). We also evaluated the correlation among FS HB, venous (ven) ZPP, FS ZPP, and ven ferritin (fer) levels as predictors of iron depletion in blood donors. We performed ven ZPP, cap ZPP, and ven fer, per directions from the equipment manufacturers (as outlined in the following paragraphs). All donors enrolled were assessed for donation eligibility via FS HB testing using a HemoCue instrument (HemoCue AB). We used a SAFE-T Fill capillary tube (RAM Scientific, Inc.) for collecting FS ZPP specimens.
Materials and Methods
For each whole blood (WB) donation, approximately 500 mL of blood was drawn or 2 units of RBCs (600 mL) were collected by automated cytapheresis collection, per bloodcenter standard operating procedures. We used diversion pouches and 2 additional specimen tubes to collect specimens for standard-donation testing.
ZPP analysis of cap and ven blood was conducted using the ProtoFluor Z instrument, model number 2005 (Helena Laboratories). ZPP values of greater than 100 μmol per mol heme were correlated with iron deficiency. We measured WB fer using spectrophotometric technique on an automated AU680 analyzer (Beckman Coulter Inc). The expected values for fer, using this method, were 16 to 243 ng per mL in men and 10 to 158 ng per mL in women. Donors were considered to have subclinical iron deficiency if the fer level was less than 26 ng per mL.
After the first donation visit, study participants were asked to complete an online survey (SurveyMonkey) designed to collect data about postdonation symptoms of anemia, vitamin use, and previous deferral from blood donation as a result of low HB levels. Study participants who reported not having an email address and/or internet access had the option to complete a paper survey ( Figure 1 ).
We analyzed data using Minitab statistical software, version 16 (Minitab Inc). Univariate linear regression analysis and correlation analysis were used to determine the relationship between the variables, namely, cap ZZP, ven ZPP, ven fer, and FS HB. We assessed the goodness of fit for the linear regression by the coefficient of determination (R 2 ). This value indicates how much of the total variation is explained by the linear regression. The correlation coefficient (R) is the square root of the coefficient of determination (R 2 ). Differences of 5% or greater were considered.
We conducted descriptive statistical analysis for data from the first and second visits. Data from volunteer blood-donor participants were arranged into strata using the following HB ranges: 12.5 to 12.9, 13.0 to 14.0, and greater than 14.0 g per dL. We calculated the mean, SE, SD, minimum, maximum, first-quartile, median, and third-quartile values for FS HB, FS ZPP, ven ZPP, and ven fer. Because the data were not normally distributed, they were log transformed for the first and second visits for further analysis.
Results
We observed subclinical iron deficiency at all 3 HB levels. The correlations for first-visit donors, comparing the variables FS HB to FS ZPP, ven ZPP to ven fer, FS ZPP to ven ZPP, FS ZPP to ven fer, and ven ZPP to ven fer, were all significant (P <.001). Logarithmic scales of these comparisons are shown in Figure 2 . The percentage of variation explained by each predictor is indicated by the R Approximately 55% (n = 181) of the donors who responded to the survey reported feeling healthy the day of donation, and 52% (n = 171) reported feeling well after donating. The vitamin-supplement usage of the respondents was reported as 8% (n = 26) taking vitamin D, 5% (n = 16) taking vitamin B, 4% (n = 12) taking iron, and 15% (n = 50) taking a multivitamin ( Table 2) . The results were inconsistent with the symptom of feeling unwell and with vitamin-supplement usage. It should be noted that 1% (n = 3) female study participants reported feeling unwell after the donation and had fer levels below 26 ng per mL, but their ZPP levels were less than 100 μmol per mol heme. Of the male participants who reported not feeling well after donation, none had fer levels below 26 ng per mL.
Discussion
Our results showed that subclinical iron deficiency was present in donors at all HB levels. In data from the first and second donation visits, P <.001, suggesting that correlation between FS HB, FS ZPP, ven ZPP, and fer values was significantly different (ie, that these values were not correlated).
This finding does not support use of FS or ven ZPP analysis as a measure of iron stores for donors before blood collection.
Symptoms reported by study participants were inconsistent with laboratory results. Based on the statistical data observed, age, sex, vitamin usage, and postdonation symptoms did not correlate with the results of the analyses. Despite feeling unwell after donation, some participants returned to donate blood a second time; some others who reported feeling well did not return and were lost to follow up.
Limitations of this study include the small sample size: only 134 participants (41%) returned for a second donation, which impacted the statistical evaluation. Also, restriction of the study to 4 donor centers was a limiting factor. In addition, the subjective nature of some of the survey questions (eg, "Do you feel healthy?") may have affected the answers provided.
There is no criterion standard for the determination of iron status in humans, to our knowledge. Fer testing is often used; however, its use has limitations. With very low fer results (12 ng/mL or less), donors can be considered to be truly iron deficient; however, frequently, donors will have higher fer results, which indicate that these individuals are subclinically iron deficient (fer <26 ng/mL). The sample of donors in this study included mostly repeat donors. Donors in this study were randomly selected, based on presentation and willingness to participate in the study. All participants met the minimum HB requirement of 12.5 g per dL or greater to be a donor; this cutoff is used as a means of assessing the iron stores needed for donors to recover from donation and to not develop anemia as part of the process.
The study results showed that it was possible to measure ZPP in a blood-donation-center environment and prevent development of the clinical symptoms associated with iron depletion; however, poor correlation between ZPP and fer assay results in this study mean that these methods are probably no better than HB at measuring iron stores. Fer may be the most useful marker for predonation assessment of iron levels in the body; however, there are technical difficulties with the use of fer assay in donor centers. The results of other studies 2, 5 have been mixed: one set of study results showed that ZPP measurements obtained at the previous visit may have added value in the risk prediction of HB deferral. Another set of study results showed that previous-visit ZPP measurements were not optimal in routine point-of-care assessment for donor iron deficiency. It also has been shown 4 that HB levels do not always correlate with fer levels: those levels dropped much more quickly in the first 3 donations during a 12-month period, compared with iron values.
A larger study is warranted to obtain a more-optimal sample size for WB donors and double-RBC donors. Such a study might allow for the establishment of a more accurate cut-off value for the use of the ZPP in this setting. Such a study also could allow for a detailed cost analysis of all iron deficiency screening tools available.
In conclusion, the symptoms reported by study participants were not consistent with any of the iron-evaluation results.
In our donor population, we found insufficient correlation between FS HB and ven fer results to support use of ZPP analysis as a tool for measurement of iron stores for blood donors before collection. LM
